Research Press Release

king hepatitis C virusAdd to my bookmarks

Nature Immunology

November 18, 2013

The mechanism by which variations in the genetic sequence near the gene encoding human interferon lambda (IFNL) are associated with clearance of the hepatitis C virus (HCV) is revealed in a report published online this week in Nature Immunology.

Ram Savan and colleagues found that one particular genetic variant produces more stable IFN-lambda messenger RNA and this leads to increased production of this anti-viral factor. The authors also find HCV tries to ‘escape’ the immune response by aiding in IFN-lambda degradation. Again, the ‘protective’ IFN-lambda variant is more resistant to this degradation process.

The identification of this resistant IFN-lambda variant may explain why certain patients successfully clear HCV following drug treatment whereas a significant minority remain chronically infected.

DOI:10.1038/ni.2758 | Original article

Research highlights

PrivacyMark System